Oppenheimer & Co’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-18,485
| Closed | -$169K | – | 1323 |
|
2020
Q1 | $169K | Buy |
18,485
+1,256
| +7% | +$11.5K | 0.01% | 1055 |
|
2019
Q4 | $240K | Buy |
17,229
+7
| +0% | +$98 | 0.01% | 1108 |
|
2019
Q3 | $296K | Sell |
17,222
-523
| -3% | -$8.99K | 0.01% | 986 |
|
2019
Q2 | $483K | Sell |
17,745
-4
| -0% | -$109 | 0.01% | 830 |
|
2019
Q1 | $339K | Buy |
17,749
+68
| +0.4% | +$1.3K | 0.01% | 979 |
|
2018
Q4 | $166K | Sell |
17,681
-6,157
| -26% | -$57.8K | 0.01% | 1133 |
|
2018
Q3 | $452K | Buy |
23,838
+1,838
| +8% | +$34.9K | 0.01% | 902 |
|
2018
Q2 | $430K | Buy |
22,000
+6,000
| +38% | +$117K | 0.01% | 926 |
|
2018
Q1 | $301K | Hold |
16,000
| – | – | 0.01% | 1055 |
|
2017
Q4 | $266K | Sell |
16,000
-1,365
| -8% | -$22.7K | 0.01% | 1108 |
|
2017
Q3 | $357K | Buy |
17,365
+1,365
| +9% | +$28.1K | 0.01% | 967 |
|
2017
Q2 | $143K | Buy |
+16,000
| New | +$143K | ﹤0.01% | 1234 |
|